Page 868 - Saunders Comprehensive Review For NCLEX-RN

cramping, bradycardia, dysrhythmias,
myocardial infarction, and severe
hypertension
b. High doses are associated with
peripheral vasospasm or
vasoconstriction, angina, miosis,
confusion, respiratory depression,
seizures, or unconsciousness; uterine
tetany can occur.
c. Contraindicated during pregnancy and
in clients with significant
cardiovascular disease, peripheral
vascular disease, or hypertension

4. Interventions

a. Monitor maternal vital signs, weight,
intake and output, level of
consciousness, and lung sounds.
b. Monitor the blood pressure closely; the
medication produces vasoconstriction,
and if an increase in blood pressure is
noted, withhold the medication and
notify the OB.
c. Monitor uterine contractions
(frequency, strength, and duration).
d. Assess for chest pain, headache,
shortness of breath, itching, pale or
cold hands or feet, nausea, diarrhea,
and dizziness.
e. Assess the extremities for color,
warmth, movement, and pain.
f. Assess vaginal bleeding.
g. Notify the OB if chest pain or other
adverse effects occur.
h. Administer analgesics as prescribed;
they may be required because the
medication produces painful uterine
contractions.

Check the client’s blood pressure before

administering methylergonovine maleate. This
medication can cause severe hypertension and is
contraindicated in a client with hypertension.
B. Prostaglandin F : carboprost tromethamine
2α
1. Description: Contracts the uterus
2. Uses: Postpartum hemorrhage

868